pharmaphorum

JULY 29, 2022

Patients with end-stage renal disease (ESRD) who are on dialysis often need to be treated with anticoagulants to prevent blood clots, but as a result, can experience bleeding side effects. Now, Ionis and Bayer think they have a new drug that could sidestep that risk.

Side effects 72

Side effects FDA Pharma Patients 72

European Pharmaceutical Review

JULY 5, 2022

There is an urgent need for more effective chemotherapy treatments with less severe toxicity and side effects. Irinotecan – also known by the brand name Campto/Camptosar ® (Pfizer Ltd.) – has proven to be an effective chemotherapy agent against several types of gastrointestinal cancer. 2015; 35(3):1437-45.

Patients 104

Patients Food and Drug Administration Side effects Safety 104

Pharmaceutical Technology

AUGUST 26, 2022

This guidance is in line with the WHO’s End TB Strategy, which aims for an 80% fall in worldwide TB incidence and a 90% decrease in TB deaths by 2030, compared with 2015. As patients with a drug-resistant form of TB cannot receive the standard regimen, their treatment courses tend to be more complex and often cause unsavoury side effects.

Side effects 98

Side effects Pharmaceutical Patients Recruitment 98

Pharmaceutical Technology

MAY 5, 2023

When used to screen adverse event reports related to cyproheptadine hydrochloride/lysine hydrochloride/vitamins, the same drug group as the highlighted case, less than half the reports list weight-related reasons for apetamin use, while 11 of the 14 reports since 2015 are deemed as ‘serious’.

Food and Drug Administration 52

Food and Drug Administration FDA Side effects Food 52

European Pharmaceutical Review

DECEMBER 14, 2023

They enable a range of observational study designs to be used where researchers study a period of exposure to a particular medicine and compare it with a control period of non-exposure in the same patient to establish any changes in the risk of adverse side effects. EMA/95098/2010. Internet] European Medicines Agency. cited Dec2023].

Medicine 116

Medicine Safety Competition Medical 116

European Pharmaceutical Review

SEPTEMBER 5, 2024

Due to the issues with Ocaliva, there is space for competitors with fewer side effects and Calliditas hopes that setanaxib will fit the bill. 2015; 23(5):358–74. A data readout from Calliditas’ Phase IIb trial in primary biliary cholangitis, comparing two doses of setanaxib with placebo, is due in Q3 2024. Cancer Research.

Medicine 59

Medicine Side effects Marketing Patients 59

PM360

AUGUST 26, 2024

Between 2015 and 2021, over a quarter of the drugs approved by the US Food and Drug Administration (FDA) were associated with specific biomarkers. Traditionally, precision medicine was defined as a targeted approach using DNA, molecular signatures, epigenetics, lifestyle, comorbidities, and other factors.

Medicine 52

Medicine Food and Drug Administration Government Insurance 52

Pharmaceutical Technology

JULY 23, 2008

Analysts predict Pfizer’s revenue stream would be slashed by 25% by 2015 if the company did not branch out into other areas. However, there’s still plenty of cancers where treatment can only prolong life by two to three months and then only with side effects that bring up serious quality of life issues.

Side effects 40

Side effects Marketing Pharmaceutical Sales 40

Celeritas

NOVEMBER 21, 2022

They only partially impact the target areas and have damaging side effects in adjacent regions. Gold nanowires further positively impact key organ transplant functions – synapse formation and stem cell differentiation – all without using growth factors, which cause negative side effects. Drug Target. 22, 576–583. [9]

Engineering 52

Engineering Transportation Side effects Networking 52

pharmaphorum

DECEMBER 15, 2022

Back in 2015, the influencer-of-influencers, Kim Kardashian, was slammed for failing to mention the potential side effects of an anti-nausea drug, leading to the US FDA getting involved. Despite the slap on the wrist, the campaign was highly effective and there is no sign of this approach going away.

Media 103

Media Healthcare Healthcare Education 103

Pharmaceutical Technology

OCTOBER 10, 2022

In 2015, the FDA approved Sprout Pharmaceuticals’s Addyi, also known under the generic name flibanserin, for use by pre-menopausal women with hypoactive sexual desire disorder (HSDD). Moreover, despite the buzz generated when Addyi was launched in 2015, only one other drug has since been marketed.

Pharmacology 59

Pharmacology Side effects FDA Safety 59

Impetus Digital

JANUARY 3, 2023

Back in 2015, the influencer-of-influencers, Kim Kardashian, was slammed for failing to mention the potential side effects of an anti-nausea drug, leading to the US FDA getting involved. Despite the slap on the wrist, the campaign was highly effective and there is no sign of this approach going away.

Media 52

Media Healthcare Healthcare Recruitment 52